The purpose of the study is to characterize the challenges to physical activity and exercise for HS patients and design an exercise program (EP) with evidence-based techniques and examine its outcome.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
50
Participants will perform a minimum of one exercise from each of the targeted muscle groups at a frequency of every other day, for a total of 3-4 days a week of exercise with a rest day. The entire strengthening exercise routine should take approximately 25-30 minutes to perform, including rest periods. Each muscle grouping of exercises is designed to progress from minimal muscle effort required to moderate to maximal effort. Participants will use a video to perform the exercises as well as a handout with specific instructions.
Participants in this group will attend one in-person visit expected to last about 60 minutes. The clinic visit will consist of standard of care procedures and tests for individuals with mild-to-severe HS .
University of Miami
Miami, Florida, United States
RECRUITINGChange in Functional Strength/Endurance as Measured by 30-second chair-stand test
Determines how many times a person can rise from a chair and sit down again in 30 seconds while keeping their arms crossed over their chest. The test will assess lower body strength and endurance and will be reported using a composite score of the number of times completed.
Time frame: Baseline and up to 12 weeks
Change in Functional Strength/Endurance as measured by six-minute walk test
Six-minute walk measures overall functioning capacity, and lower body muscle strength/ endurance, with a composite score reported in meters.
Time frame: Baseline and up to 12 weeks
Change in Functional Strength as measured by hand grip strength test
It is a measure of upper body muscular strength measured in kilograms.
Time frame: Baseline and up to 12 weeks
Quality of life impairment as measured by the DLQI
Dermatology Life Quality Index (DLQI) has a total score ranging from 0 to 30 with the lower score indicating higher health related quality of life.
Time frame: Baseline, up to 12 weeks
Quality of life impairment as measured by the HiSQOL
Hidradenitis Suppurativa Quality of Life (HiSQOL) has a total score ranging from 0 to 68 with the lower score indicating higher health related quality of life.
Time frame: Baseline, up to 12 weeks
Change in Physical activity as measured by the International Physical Activity Questionnaire (IPAQ)
IPAQ assesses 3 types of physical activity undertaken across the 4 domains- leisure time physical activity; domestic and gardening (yard) activities; work-related physical activity; transport-related physical activity- in the previous 7 days. The 3 types of activity assessed are walking, moderate-intensity activities and vigorous-intensity activities. The result s is not reported in scales. Computation of the total score for the IPAQ requires summation of the duration (in minutes) and frequency (days) of the 3 types of activities across the 4 domains. Higher result indicates higher physical activity in the last 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Baseline, up to 12 weeks
Change in Level of Activity as measured by the average number of steps daily
Average number of steps daily will be measured with a pedometer and will be reported.
Time frame: Baseline, up to 12 weeks
Change in Severity of HS score using the IHS-4
The International Hidradenitis Suppurativa Severity Score System (IHS4) measures HS severity as mild (0-3), moderate (4-10), severe (≥11). Higher score indicate increased severity.
Time frame: Baseline, up to 12 weeks
Average pain as assessed by the Numerical Rating Scale (NRS)
The average pain will be measured using the NRS with scores ranging from 0-10 with the higher score indicating more severe pain.
Time frame: Up to 8 weeks